FDA Recalls Eczema Cream Due to Deadly Bacteria Risk, Affecting Millions
The FDA has issued a nationwide recall for MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, sold by Wisconsin-based Pharmacal, due to potential contamination with Staphylococcus aureus. This bacterium can cause severe infections, particularly in individuals with weakened immune systems or compromised skin. The recall affects products sold in H-E-B grocery stores and on Amazon, specifically the 6-ounce tube with product code 5106 and UPC 012277051067, set to expire in November 2026. The FDA classified this as a Class II recall, indicating that exposure could lead to temporary or medically reversible health issues. Pharmacal is coordinating with distributors for the return of the recalled products, and consumers are advised to check labels and discard any affected items. No adverse events have been reported so far. 
